Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Taube, Joseph H ^a   Malouf, Gabriel G ^a,b   Lu, Emily ^c   Sphyris, Nathalie ^a   Vijay, Vidya ^a   Ramachandran, Priyanka P ^a   Ueno, Katumasa R ^a   Gaur, Sanchaika ^a   Nicoloso, Milena S ^a   Rossi, Simona ^a   Herschkowitz, Jason I ^d   Rosen, Jeffrey M ^d   Issa, Jean Pierre J ^e   Calin, George A ^a   Chang, Jeffrey T ^c,f   Mani, Sendurai A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b INSERM   (France)

^c UNIVERSITY OF TEXAS   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DKK1 PROTEIN, HUMAN; MICRORNA; MIRN203 MICRORNA, HUMAN; SIGNAL PEPTIDE;

ANIMAL; ARTICLE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL TRANSFORMATION; CPG ISLAND; DNA METHYLATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; METASTASIS; MOUSE; NEOPLASM; PARACRINE SIGNALING; PATHOLOGY; PROMOTER REGION; TRANSFORMED CELL LINE; XENOGRAFT;

ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HETEROGRAFTS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICRORNAS; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC STEM CELLS; PARACRINE COMMUNICATION; PROMOTER REGIONS, GENETIC;

EID: 84901471917     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02687     Document Type: Article

References (51)

1. Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J Clin Invest 119, 1420-1428 (2009).
2. Polyak, K. & Weinberg, R. A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9, 265-273 (2009).
3. Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2, 442-454 (2002).
4. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008).
5. Tsai, J. H., Donaher, J. L., Murphy, D. A., Chau, S. & Yang, J. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22, 725-736 (2012).
6. Dykxhoorn, D. M. et al. miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One 4, e7181 (2009).
7. Graff, J. R., Gabrielson, E., Fujii, H., Baylin, S. B. & Herman, J. G. Methylation patterns of the E-cadherin 59 CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression duringmetastatic progression. J Biol Chem 275, 2727-2732 (2000).
8. Wu, C. Y., Tsai, Y. P., Wu, M. Z., Teng, S. C. & Wu, K. J. Epigenetic reprogramming and post-transcriptional regulation during the epithelialmesenchymal transition. Trends Genet 28, 454-463 (2012).
9. Wu, M. Z. et al. Interplay between HDAC3 and WDR5 is essential for hypoxiainduced epithelial-mesenchymal transition. Mol Cell 43, 811-822 (2011).
10. McDonald, O. G., Wu, H., Timp, W., Doi, A. & Feinberg, A. P. Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nat Struct Mol Biol 18, 867-874 (2011).
11. Wang, Y. & Shang, Y. Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis. Exp Cell Res 319, 160-169 (2013).
12. Kanai, Y., Ushijima, S., Tsuda, H., Sakamoto, M. & Hirohashi, S. Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis. Cancer Lett 148, 73-80 (2000).
13. Nass, S. J. et al. Aberrant methylation of the estrogen receptor and E-cadherin 59 CpG islands increases with malignant progression in human breast cancer. Cancer Res 60, 4346-4348 (2000).
14. Bullock, M. D., Sayan, A. E., Packham, G. K. & Mirnezami, A. H. MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression. Biol Cell 104, 3-12 (2012).
15. Nicoloso, M. S., Spizzo, R., Shimizu, M., Rossi, S. & Calin, G. A.MicroRNAs - the micro steering wheel of tumour metastases. Nat Rev Cancer 9, 293-302 (2009).
16. Park, S. M., Gaur, A. B., Lengyel, E. & Peter, M. E. ThemiR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22, 894-907 (2008).
17. Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10, 593-601 (2008).
18. Bracken, C. P. et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 68, 7846-7854 (2008).
19. Vrba, L. et al. Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS One 5, e8697 (2010).
20. Neves, R. et al. Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells. BMC Res Notes 3, 219 (2010).
21. Tellez, C. S. et al. EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. Cancer Res 71, 3087-3097 (2011).
22. Majid, S. et al. miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. Cancer Res 72, 6435-6446 (2012).
23. Yi, R., Poy, M. N., Stoffel, M. & Fuchs, E. A skin microRNA promotes differentiation by repressing 'stemness'. Nature 452, 225-229 (2008).
24. Jackson, S. J. et al. Rapid and widespread suppression of self-renewal by microRNA-203 during epidermal differentiation. Development 140, 1882-1891 (2013).
25. Elenbaas, B. et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15, 50-65 (2001).
26. Yang, J. et al. Twist, amaster regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939 (2004).
27. Wang, C., Zheng, X., Shen, C. & Shi, Y. MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triplenegative breast cancer cells. J Exp Clin Cancer Res 31, 58 (2012).
28. van Kempen, L. C. et al. Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneousmelanoma is associated with increased thickness and disease progression. Virchows Arch 461, 441-448 (2012).
29. Dontu, G. et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17, 1253-1270 (2003).
30. Al-Hajj, M.,Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100, 3983-3988 (2003).
31. Yang, J.&Weinberg, R. A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14, 818-829 (2008).
32. Hu, Y. & Smyth, G. K. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 347, 70-78 (2009).
33. Rask, L., Fregil, M., Hogdall, E., Mitchelmore, C. & Eriksen, J. Development of a metastatic fluorescent Lewis Lung carcinoma mouse model: Identification of mRNAs and microRNAs involved in tumor invasion. Gene 517, 72-81 (2013).
34. Taube, J. H. et al. Core epithelial-to-mesenchymal transition interactome geneexpression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A 107, 15449-15454 (2010).
35. Betel, D., Wilson, M., Gabow, A., Marks, D. S. & Sander, C. The microRNA.org resource: targets and expression. Nucleic Acids Res 36, D149-153 (2008).
36. Tiberio, R. et al. Keratinocytes enriched for stem cells are protected from anoikis via an integrin signaling pathway in a Bcl-2 dependent manner. FEBS Lett 524, 139-144 (2002).
37. Kuhnert, F. et al. Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc Natl Acad Sci U S A 101, 266-271 (2004).
38. Bafico, A., Liu, G., Goldin, L., Harris, V. & Aaronson, S. A. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 6, 497-506 (2004).
39. Li, Y., Lu, W., King, T. D., Liu, C. C., Bijur, G. N. & Bu, G. Dkk1 stabilizes Wnt coreceptor LRP6: implication for Wnt ligand-induced LRP6 down-regulation. PLoS One 5, e11014 (2010).
40. De Craene, B. & Berx, G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13, 97-110 (2013).
41. Morel, A. P., Lievre, M., Thomas, C., Hinkal, G., Ansieau, S. & Puisieux, A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3, e2888 (2008).
42. Wellner, U. et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11, 1487-1495 (2009).
43. Shimono, Y. et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138, 592-603 (2009).
44. Qu, Y. et al. MiR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells. Int J Cancer 133, 544-555 (2013).
45. DeCastro, A. J. et al. MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of DeltaNP63alpha and promotes mesenchymal-to-epithelial transition. Cell Death Dis 4, e514 (2013).
46. Ding, X., Park, S. I., McCauley, L. K. & Wang, C. Y. Signaling between Transforming Growth Factor beta (TGF-beta) and Transcription Factor SNAI2 Represses Expression of MicroRNA miR-203 to Promote Epithelial-Mesenchymal Transition and Tumor Metastasis. J Biol Chem 288, 10241-10253 (2013).
47. Korpal, M. et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. NatMed 17, 1101-1108 (2011).
48. 2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 41, 365-370 (2009).
49. Calin, G. A. & Croce, C. M. Investigation of microRNA alterations in leukemias and lymphomas. Methods Enzymol 427, 193-213 (2007).
50. Challen, G. A. et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet 44, 23-31 (2011).
51. Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad SciUS A98, 5116-5121 (2001).